SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astonea Labs Ltd (544409) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 544409 NSE: | Pharmaceuticals & Drugs | Small Cap

Astonea Labs Share Price

155 0.00 (0.00%)
As on 17-Apr'26 16:59

Astonea Labs Ltd (544409)

BSE: 544409 NSE:
Key Metrics
Market Cap
₹163 Cr.
P/E Ratio
30.45
Price to Book (P/B)
7.68
Price to Sales (P/S)
1.67
EV/EBITDA
13.96
Return on Capital Employed (ROCE)
17.31%
Current Price
₹155
Return on Equity (ROE)
35.36%
Return on Assets (ROA)
5.78%
Operating Profit Margin
15.7%
Net Profit Margin
5.49%
Gross Profit Margin
12%
Book Value per Share
₹20.2
Sales Growth (YoY)
21.61%
Sales Growth (3 Years)
48.04%
Operating Profit Growth (1 Year)
28.36%
Operating Profit Growth (3 Years)
37.93%
Net Profit Growth (1 Year)
31.45%
52-Week Low / High
₹118 / 185
Net Profit Growth (3 Years)
178.09%
Dividend Yield
0.00%
Promoter Holding
72.30%
Pledged shares (%)
of Promoter's holding (%)
0.00%

Check Before You Invest

Q.1 Revenue growth of Astonea Labs Ltd?
Astonea Labs Ltd revenue growth is 21.6% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.
Q.1 Promoter shareholding and pledge status of Astonea Labs Ltd?
Promoters hold 72.30% of the Astonea Labs Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Revenue growth of Astonea Labs Ltd vs industry peers?
Astonea Labs Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.54% , indicating stable growth and maintaining its market share.
Q.1 Which industry/sub-sector does Astonea Labs Ltd belong to?
Astonea Labs Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.1 Stock return of Astonea Labs Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

DeciZen - make an informed investing decision on Astonea Labs

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Astonea Labs stock performance

Key Ratios
mw4me loader

Is Astonea Labs Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Astonea Labs Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 5.8%8.4%17%17.3%-
Value Creation
Index
-0.6-0.40.20.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 30.167.180.297.598
Sales YoY Gr.-123.1%19.6%21.6%-
Adj EPS 0.20.75.36.95.1
YoY Gr.-200%641.7%29.8%-
BVPS (₹) 9.910.715.623.920.2
Adj Net
Profit
0.20.64.15.45
Cash Flow from Ops. -4.9-1.17.99.3-
Debt/CF from Ops. -6-34.35.45.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA48%21.6%
Adj EPS NANA206.8%29.8%
BVPSNANA34.2%52.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2.5740.635.423.1
Op. Profit
Mgn %
19.410.714.915.7NAN
Net Profit
Mgn %
0.60.85.15.55.5
Debt to
Equity
3.94.43.62.9-
Working Cap
Days
02042292450
Cash Conv.
Cycle
080941140

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 5.1 -
TTM Sales (₹ Cr.) 97.5 -
BVPS (₹) 20.2 -
Reserves (₹ Cr.) 11 -
P/BV 7.68 -
PE 30.45 -
From the Market
52 Week Low / High (₹) 118.00 / 185.00
All Time Low / High (₹) 118.00 / 185.00
Market Cap (₹ Cr.) 163
Equity (₹ Cr.) 10.5
Face Value (₹) 10
Industry PE 42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Astonea Labs - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales30678098
Operating Expenses + 24606882
Manufacturing Costs2547
Material Costs19505667
Employee Cost 2356
Other Costs 2233
Operating Profit 671215
Operating Profit Margin (%) 19.4%10.6%14.9%15.7%
Other Income + 0000
Exceptional Items 0000
Interest 2234
Depreciation 4445
Profit Before Tax 1157
Tax 0012
Profit After Tax 0145
PAT Margin (%) 0.8%1.0%5.1%5.5%
Adjusted EPS (₹)0.30.95.46.9
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 781218
Share Capital 4488
Reserves 34411
Debt +27334151
Long Term Debt22192022
Short Term Debt5142129
Minority Interest0000
Trade Payables14182326
Others Liabilities 4668
Total Liabilities 536481104

Fixed Assets

Net Fixed Assets +21212225
Gross Block28313543
Accumulated Depreciation7101418
CWIP 0025
Investments 0000
Inventories7172529
Trade Receivables19192538
Cash Equivalents 0000
Others Assets 5876
Total Assets 536481104

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -5-189
PBT 1157
Adjustment 5668
Changes in Working Capital -10-8-2-2
Tax Paid -1-0-1-2
Cash Flow From Investing Activity + -3-3-8-11
Capex -3-3-7-11
Net Investments 00-0-0
Others 00-1-0
Cash Flow From Financing Activity + 84-02
Net Proceeds from Shares 0001
Net Proceeds from Borrowing 6-312
Interest Paid -2-2-1-1
Dividend Paid 0000
Others 3900
Net Cash Flow -00-1-0

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.328.540.6835.36
ROCE (%)5.828.4216.9617.31
Asset Turnover Ratio0.571.141.11.05
PAT to CFO Conversion(x)N/A-121.8
Working Capital Days
Receivable Days235104101118
Inventory Days876594101
Payable Days273116131135

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Astonea Labs Ltd FAQs

The current trading price of Astonea Labs on 17-Apr-2026 16:59 is ₹155.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Astonea Labs stood at ₹162.9 Cr

The latest P/E ratio of Astonea Labs as of 16-Apr-2026 is 30.45.

The latest P/B ratio of Astonea Labs as of 16-Apr-2026 is 7.68.

The 52-week high of Astonea Labs is ₹185.0 and the 52-week low is ₹118.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Astonea Labs is ₹97.52 ( Cr.) .

About Astonea Labs Ltd

Astonea Labs Limited was originally incorporated as a private limited company in the name of ‘AHU Laboratories Private Limited’ on April 11, 2017, pursuant to the provisions of the Companies Act, 2013, and was granted a certificate of incorporation dated April 11, 2017, by the Deputy Registrar of Companies, Chandigarh. Further, the name of the company was changed from ‘AHU Laboratories Private Limited’ to ‘Astonea Labs Private Limited’ pursuant to a special resolution passed in the EGM of its members held on February 14, 2019. A fresh certificate of incorporation dated February 26, 2019, was issued by the Registrar of Companies, Chandigarh. The company was converted from a private limited company to a public limited company, pursuant to a special resolution passed in the EGM of its members held on January 02, 2024, and consequently, the name of the company was changed to ‘Astonea Labs Limited’ by deletion of the word ‘private’. A fresh certificate of incorporation consequent upon conversion from a private company to a public company dated January 11, 2024, was issued by the Registrar of Companies, Chandigarh.

The company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins. It also offers products for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums. All its products adhere to the rigorous standards of the pharmaceutical and cosmetics industries. Additionally, it is involved in the trading of certain packing materials and raw materials used in pharmaceutical and cosmetic products. 

The company is based in Haryana, India equipped with a state-of-the-art manufacturing facility, meticulously designed and operated in strict conformity with ISO standards. The company is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally. In addition to contract manufacturing, it manufactures and markets its own products under the brands ‘Glow Up’ and ‘Regero’ in the domestic market, wherein the products under Glow Up are also available through e-commerce platforms like Amazon and Tata 1MG. 

Business area of the company

The company is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally.

Awards, accreditations, or recognition

  • March 17, 2021: Certificate of Compliance issued by UK Global Certification and Inspection Limited for manufacturing of personal care, face, and hair care products.
  • March 12, 2022: Certificate of Compliance issued by UK Global Certification and Inspection Limited for manufacturing of cream, lotion, gel, ointments, aerosol, paste, soap, tablets, soft gels, powders, capsules, liquid & extracts who meet the requirements of WHO - GMP.
  • April 07, 2022: Certificate of Compliance issued by UK Global Certification and Inspection Limited for being compliant with the requirements of ISO 22716:2007 in respect of manufacturing cream, lotion, gel, ointment, aerosol, paste, soap, tablets, soft gels, powders, capsules, liquid & extracts.
  • April 08, 2022: Halal Certificate issued by UK Global Certification and Inspection for manufacturing of cream, lotion, gel, ointments, aerosol, paste, soap, tablets, soft gels, powders, capsules, liquid & extracts.
  • April 08, 2022: ISO 22000:2018 (Food safety management system) and ISO 9001:2015 (Quality management system) issued by SM Certification Services for manufacturing of cream, lotion, gel, ointment, aerosol, paste, soap, tablets, softgels, powders, capsules, liquid & extracts.
  • April 28, 2023: Site Certificate issued by State Drugs Controller-Cum-Controlling and Licensing Authority, Haryana for maintaining good manufacturing system and being compliant with the requirements of WHO-GMP for manufacturing cream, lotion, gel, ointment, aerosol, paste, soap, tablets, softgels, powders, capsules, liquid & extracts.
  • October 14, 2023: ZED Bronze Certificate issued under MSME Sustainable (ZED) Certification Scheme, for fulfilling the requirements as mentioned in the guidelines for this certification while manufacturing pharmaceuticals, medicinal chemicals, and botanical products.
  • April 22, 2024: GMP Certificate issued by the State Drugs Controller, Haryana for ensuring good manufacturing practices.
  • April 22, 2024: Site Certificate issued by State Drugs Controller-Cum-Controlling and Licensing Authority, Haryana for maintaining good manufacturing system at the site and being compliant with the requirements of WHO-GMP while manufacturing tablets, capsules, oral powders and other external preparations.
  • May 28, 2024 ISO 9001:2015 (Quality management system) and ISO 22000:2018 (Food safety management system) issued by United Kingdom Global Accreditation for manufacturers of tablets, capsules (soft gelatin and hard gelatin) oral powders and other external preparations.
  • May 28, 2024: Certificate of Compliance issued by United Kingdom Global Accreditation for being compliant with the requirements of ISO 22716:2007 (Cosmetics-good manufacturing practices) (GMP) for manufacturers the categories: - A, C, H, K & L.
  • May 28, 2024: ORGANIC Certificate of Compliance issued United Kingdom Global Accreditation for manufacturers of tablets, capsules (soft gelatin and hard gelatin), oral powders and other external preparations & cosmetic categories: - A, C, H, K & L.

History and milestones

  • 2017: Incorporation of the Company in the name of AHU Laboratories Private Limited and acquisition of 2.5 acres of land for setting up a manufacturing facility at VillageHaripur, Tehsil- Raipur Rani, District- Panchkula, Haryana (Manufacturing Facility).
  • 2018: Construction of manufacturing facility and procurement of plant and machinery.
  • 2019: Changed the name of the company from AHU Laboratories Private Limited to Astonea Labs Private Limited.
  • 2019: Started production with cosmetic block at the Manufacturing Facility.
  • 2020: Started export with merchant exporter.
  • 2021: Started second block with pharmaceutical products such as tablet, capsules, softgel, and oral powder production at the Manufacturing Facility.
  • 2022: Started direct export of the pharmaceutical products Launched the brand ‘Glowup’.
  • 2023: Received certification under WHO / GMP certification scheme and Eco-cert COSMOS.
  • 2024: Launched the brand ‘Regero’.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×